|
|
Volumn 3, Issue 1, 2007, Pages 1-
|
|
The pitfalls in the development of biologic therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRHEUMATIC AGENT;
CORTICOSTEROID;
DISEASE MODIFYING ANTIRHEUMATIC DRUG;
TUMOR NECROSIS FACTOR ANTAGONIST;
UNCLASSIFIED DRUG;
ANKYLOSING SPONDYLITIS;
AUTOIMMUNE DISEASE;
CANCER RISK;
CHRONIC DISEASE;
DRUG COST;
EDITORIAL;
ENTERITIS;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION RISK;
NONHUMAN;
PRIORITY JOURNAL;
PSORIATIC ARTHRITIS;
RHEUMATOID ARTHRITIS;
TREATMENT INDICATION;
ANTIBODIES, MONOCLONAL;
ARTHRITIS, RHEUMATOID;
BIOLOGICAL THERAPY;
DRUG APPROVAL;
DRUG DESIGN;
DRUG INDUSTRY;
HUMANS;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 33846955050
PISSN: 17458382
EISSN: 17458390
Source Type: Journal
DOI: 10.1038/ncprheum0373 Document Type: Editorial |
|
Times cited : (6)
|
|
References (0)
|
